Skip to main content

Table 1 Key R&D, publication, patenting, and pharmaceutical market indicators for China, India, Brazil, South Africa and select developed markets

From: Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators

Country R&D Expenditure as a % of GDP1 Gross Expenditure on R&D in Billions USD1 Share of Global Scientific Publications
[Annual Growth Rate b/w 2000–2008]2
Annual Growth Rate in Patenting (2000–2006)2 Pharmaceutical Market Size, Billions USD, 2010 (Projected Size in 2015)3 CAGR for Pharmaceutical Market, 2006–2010 (2010–2015 Forecast)3
China 1.5 (2008) 102 12%, [23.4%] 26.5% 25.7 (48.8) 17.3% (13.6%)
India 0.80 24.8 2.3%, [4.7%]** 42%* 14.1 (30.4) 16.6% (16.6%)
Brazil 1.10 20.3 1.6%, [12.2%]*** N/A 15.3 (34.4) 13.1% (17.6%)
Canada 1.84 (2008) 24.0 2.7% 3.9% 26.6 (30.2) 5.4% (2.6%)
Germany 2.54 72.2 4%08 5.7% 37.9 (41.5) 3.4% (1.8%)
Japan 3.44 148 4.8% 4.5% 72.4 (102.7) 4.4% (7.2%) ****
United States 2.82 (2008) 398 16% 2.6% 292.8 (344.7) 2.9% (3.3%)
  1. Sources: 1 UNESCO Science Report 2010. Data is for 2007 unless stated otherwise.
  2. 2 OECD Science, Technology and Industry Outlook 2010. Share of publications is for 2008, except for India where this share represents 2006 Data.
  3. 3 DataMonitor 2010, Country-specific Pharmaceutical Industry Profile Reports.
  4. * Estimate for India is for period 1997–2004.
  5. ** Estimate for India is for 1995–2005.
  6. *** Estimate for Brazil is for 1998–2008.
  7. **** Data for 2005–2009 and 2009–1014.
  8. CAGR stands for Cumulative Annual Growth Rate.